Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting

Citation
Zq. Yao et al., Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting, VACCINE, 19(13-14), 2001, pp. 1628-1635
Citations number
47
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
19
Issue
13-14
Year of publication
2001
Pages
1628 - 1635
Database
ISI
SICI code
0264-410X(20010208)19:13-14<1628:SMIACK>2.0.ZU;2-5
Abstract
The major target of human cytomegalovirus (CMV)-specific cytotoxic T lympho cytes (CTL) is the tegument protein CMVpp65. However, this protein has prot ein kinase (PK) activity, and the unknown effects on cell replication of an exogenous PK in healthy cells could limit the use of CMVpp65 as a vaccine, especially in children. In this report we show that a point mutation conve rting lysine to asparagine at the invariant lysine (K436), an essential sit e for phosphotransfer, abolishes the threonine kinase activity. The mutant CMVpp65 maintains its immunologic target characteristics, including antibod y and CTL reactivity. This kinase-deficient CMVpp65 is a candidate for eval uation in future CMV vaccine development. (C) 2001 Published by Elsevier Sc ience Ltd.